Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 34% ± 13% | |
ciliated cell | 6 studies | 26% ± 11% | |
basal cell | 6 studies | 30% ± 15% | |
neuron | 5 studies | 30% ± 14% | |
epithelial cell | 5 studies | 38% ± 20% | |
retina horizontal cell | 5 studies | 40% ± 10% | |
Mueller cell | 5 studies | 37% ± 22% | |
endothelial cell | 4 studies | 30% ± 16% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 9% | |
smooth muscle cell | 4 studies | 18% ± 2% | |
interneuron | 3 studies | 34% ± 17% | |
placental villous trophoblast | 3 studies | 26% ± 3% | |
amacrine cell | 3 studies | 30% ± 12% | |
fibroblast | 3 studies | 21% ± 5% | |
adipocyte | 3 studies | 21% ± 5% | |
GABAergic neuron | 3 studies | 34% ± 13% | |
glutamatergic neuron | 3 studies | 37% ± 14% | |
oligodendrocyte | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5306.32 | 1439 / 1445 | 99% | 35.42 | 182 / 183 |
breast | 100% | 5793.23 | 458 / 459 | 96% | 36.32 | 1069 / 1118 |
intestine | 100% | 4720.73 | 962 / 966 | 94% | 14.80 | 497 / 527 |
lung | 98% | 2120.43 | 565 / 578 | 94% | 20.17 | 1084 / 1155 |
ovary | 100% | 4716.46 | 180 / 180 | 91% | 19.77 | 393 / 430 |
prostate | 100% | 8223.55 | 245 / 245 | 91% | 23.05 | 458 / 502 |
stomach | 97% | 3300.85 | 349 / 359 | 93% | 17.31 | 266 / 286 |
thymus | 100% | 6911.35 | 652 / 653 | 90% | 24.62 | 543 / 605 |
bladder | 100% | 4701.52 | 21 / 21 | 87% | 15.68 | 439 / 504 |
adrenal gland | 100% | 11494.49 | 258 / 258 | 87% | 18.21 | 200 / 230 |
uterus | 100% | 5291.17 | 170 / 170 | 86% | 22.80 | 397 / 459 |
pancreas | 90% | 1420.96 | 295 / 328 | 90% | 15.58 | 160 / 178 |
brain | 82% | 1379.67 | 2170 / 2642 | 95% | 31.47 | 672 / 705 |
skin | 100% | 6913.95 | 1804 / 1809 | 65% | 7.45 | 308 / 472 |
kidney | 90% | 1663.55 | 80 / 89 | 70% | 7.83 | 628 / 901 |
adipose | 100% | 2741.13 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3672.57 | 1328 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 4040.98 | 798 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 32.27 | 42 / 45 |
heart | 70% | 983.68 | 599 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 4.93 | 48 / 80 |
liver | 14% | 150.47 | 31 / 226 | 36% | 4.08 | 147 / 406 |
spleen | 43% | 544.36 | 104 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 7% | 88.20 | 62 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0099173 | Biological process | postsynapse organization |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0030011 | Biological process | maintenance of cell polarity |
GO_0072205 | Biological process | metanephric collecting duct development |
GO_0007165 | Biological process | signal transduction |
GO_0060441 | Biological process | epithelial tube branching involved in lung morphogenesis |
GO_0045176 | Biological process | apical protein localization |
GO_0045186 | Biological process | zonula adherens assembly |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0071896 | Biological process | protein localization to adherens junction |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0035332 | Biological process | positive regulation of hippo signaling |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0060563 | Biological process | neuroepithelial cell differentiation |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0060999 | Biological process | positive regulation of dendritic spine development |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0045197 | Biological process | establishment or maintenance of epithelial cell apical/basal polarity |
GO_0030901 | Biological process | midbrain development |
GO_0030859 | Biological process | polarized epithelial cell differentiation |
GO_0035331 | Biological process | negative regulation of hippo signaling |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005912 | Cellular component | adherens junction |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0030054 | Cellular component | cell junction |
GO_0036064 | Cellular component | ciliary basal body |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DLG5 |
Protein name | Disks large homolog 5 Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) Discs large MAGUK scaffold protein 5 (Disks large homolog 5) Alternative protein DLG5 |
Synonyms | KIAA0583 PDLG |
Description | FUNCTION: Acts as a regulator of the Hippo signaling pathway . Negatively regulates the Hippo signaling pathway by mediating the interaction of MARK3 with STK3/4, bringing them together to promote MARK3-dependent hyperphosphorylation and inactivation of STK3 kinase activity toward LATS1 . Positively regulates the Hippo signaling pathway by mediating the interaction of SCRIB with STK4/MST1 and LATS1 which is important for the activation of the Hippo signaling pathway. Involved in regulating cell proliferation, maintenance of epithelial polarity, epithelial-mesenchymal transition (EMT), cell migration and invasion . Plays an important role in dendritic spine formation and synaptogenesis in cortical neurons; regulates synaptogenesis by enhancing the cell surface localization of N-cadherin. Acts as a positive regulator of hedgehog (Hh) signaling pathway. Plays a critical role in the early point of the SMO activity cycle by interacting with SMO at the ciliary base to induce the accumulation of KIF7 and GLI2 at the ciliary tip for GLI2 activation (By similarity). . |
Accessions | Q8TDM6 ENST00000424842.5 ENST00000614211.2 [Q8TDM6-1] A0A0A0MSL1 R4GMQ2 ENST00000632221.1 A0A0J9YYG8 L8EAB8 ENST00000468332.6 ENST00000633108.1 ENST00000632417.1 ENST00000372391.7 [Q8TDM6-1] |